The predictive value of PD‐L1 expression in patients with advanced hepatocellular carcinoma treated with PD‐1/PD‐L1 inhibitors: A systematic review and meta‐analysis

BACKGROUND AND AIM: Programmed death 1 (PD‐1) and programmed death ligand 1 (PD‐L1) inhibitors have transformed the treatment landscape of advanced hepatocellular carcinoma (HCC), but consistent responses are not observed in all patients, and prognostic biomarkers to guide treatment decisions are la...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yao, Chen, Dongbo, Zhao, Bigeng, Ren, Liying, Huang, Rui, Feng, Bo, Chen, Hongsong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166972/
https://www.ncbi.nlm.nih.gov/pubmed/36965092
http://dx.doi.org/10.1002/cam4.5676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166972/
https://www.ncbi.nlm.nih.gov/pubmed/36965092
http://dx.doi.org/10.1002/cam4.5676

Ejemplares similares